CCM
Consonance Capital Management Portfolio holdings
AUM
$7.28M
This Quarter Return
+4.43%
1 Year Return
-42.86%
3 Year Return
+319.33%
5 Year Return
+899.35%
10 Year Return
–
AUM
$23.7M
AUM Growth
+$23.7M
(-60%)
Cap. Flow
-$26M
Cap. Flow
% of AUM
-109.56%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
–
Reduced
5
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
Tandem Diabetes Care
TNDM
|
$8.46M |
| 2 |
Globus Medical
GMED
|
$5.7M |
| 3 |
United Therapeutics
UTHR
|
$5.08M |
| 4 |
Compass Therapeutics
CMPX
|
$4.99M |
| 5 |
MoonLake Immunotherapeutics
MLTX
|
$1.52M |
Sector Composition
| 1 | Healthcare | 99.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Surrozen
SRZN
$104M
| $10.5M | 44.25% | 3,497,500 | – | – |
|
|
SLN
2
Silence Therapeutics
SLN
$227M
| $7.52M | 31.7% | 634,270 -19,838 | -3% | -$235K |
|
|
3
Compass Therapeutics
CMPX
$483M
| $4.22M | 17.79% | 1,603,789 -1,896,211 | -54% | -$4.99M |
|
|
4
United Therapeutics
UTHR
$13.8B
| $706K | 2.98% | 2,998 -21,565 | -88% | -$5.08M |
|
|
5
Globus Medical
GMED
$8.27B
| $303K | 1.28% | 5,405 -101,619 | -95% | -$5.7M |
|
|
6
Tandem Diabetes Care
TNDM
$845M
| $254K | 1.07% | 4,294 -143,033 | -97% | -$8.46M |
|
|
7
Surrozen, Inc. Warrant
SRZNW
$71.6K
| $223K | 0.94% | 1,165,832 | – | – |
|
|
8
MoonLake Immunotherapeutics
MLTX
$3.54B
| – | – | -137,000 | Closed | -$1.52M |
|